Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

In Sil Choi

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Plos One|October 23, 2018
A population-based outcomes study of patients with metastatic gastric cancer receiving second-line chemotherapy: A nationwide health insurance database studyIn Sil Choi, Jee Hyun Kim, Ju Hyun Lee, et al.
Diagnostic Pathology|June 6, 2020
Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomasEuno Choi, Mee Soo Chang, Sun-Ju Byeon, et al.
Cancer Research and Treatment|January 24, 2017
CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin ChemotherapyDae-Won Lee, Seock-Ah Im, Yu Jung Kim, et al.
Cancer Science|January 6, 2010
Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6Sae-Won Han, Do-Youn Oh, Seock-Ah Im, et al.
Japanese Journal of Clinical Oncology|December 8, 2005
Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancerKeun-Wook Lee, Seock-Ah Im, Tak Yun, et al.
Annals of Hematology|January 28, 2009
Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvementKeun-Wook Lee, Jongyoun Yi, In Sil Choi, et al.
Plos One|June 8, 2018
Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes studyIn Sil Choi, Mihong Choi, Ju Hyun Lee, et al.
Cancer Research and Treatment|May 26, 2023
A Phase 3 Randomized Clinical Trial to Compare Efficacy and Safety between Combination Therapy and Monotherapy in Elderly Patients with Advanced Gastric Cancer (KCSG ST13-10)Keun-Wook Lee, Dae Young Zang, Min-Hee Ryu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2005
Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinibSae-Won Han, Tae-You Kim, Pil Gyu Hwang, et al.
Journal of Korean Medical Science|December 6, 2007
Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancerKeun Wook Lee, Jee Hyun Kim, Tak Yun, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Plos One|October 23, 2018
A population-based outcomes study of patients with metastatic gastric cancer receiving second-line chemotherapy: A nationwide health insurance database studyIn Sil Choi, Jee Hyun Kim, Ju Hyun Lee, et al.
Diagnostic Pathology|June 6, 2020
Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomasEuno Choi, Mee Soo Chang, Sun-Ju Byeon, et al.
Cancer Research and Treatment|January 24, 2017
CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin ChemotherapyDae-Won Lee, Seock-Ah Im, Yu Jung Kim, et al.
Cancer Science|January 6, 2010
Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6Sae-Won Han, Do-Youn Oh, Seock-Ah Im, et al.
Japanese Journal of Clinical Oncology|December 8, 2005
Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancerKeun-Wook Lee, Seock-Ah Im, Tak Yun, et al.
Annals of Hematology|January 28, 2009
Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvementKeun-Wook Lee, Jongyoun Yi, In Sil Choi, et al.
Plos One|June 8, 2018
Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes studyIn Sil Choi, Mihong Choi, Ju Hyun Lee, et al.
Cancer Research and Treatment|May 26, 2023
A Phase 3 Randomized Clinical Trial to Compare Efficacy and Safety between Combination Therapy and Monotherapy in Elderly Patients with Advanced Gastric Cancer (KCSG ST13-10)Keun-Wook Lee, Dae Young Zang, Min-Hee Ryu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2005
Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinibSae-Won Han, Tae-You Kim, Pil Gyu Hwang, et al.
Journal of Korean Medical Science|December 6, 2007
Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancerKeun Wook Lee, Jee Hyun Kim, Tak Yun, et al.
Pageof 7